Does psyllium husk help with constipation?

Yes, modestly, in adults with chronic constipation. Pooling 3 placebo-controlled trials in 258 people for its 2023 guideline, the American Gastroenterological Association and American College of Gastroenterology found psyllium may add about 2.3 spontaneous bowel movements a week, with an interval from 0.86 to 3.79. In 2 of those trials, global relief came to 391 more people per 1,000. They graded that evidence low certainty. Across all fiber supplements, not psyllium alone, benefit came at doses above 10 g a day, and the British Dietetic Association advises at least 4 weeks before judging the result.

Established. Psyllium works better than control for chronic constipation in adults. A 2022 meta-analysis found the 3 psyllium trials raised the chance of responding by 82%, a risk ratio of 1.82 from 1.51 to 2.20, with no disagreement between trials. Across all fiber types in the same analysis, 66% responded against 41% on control.

Unsettled. The size of the effect is less settled than its direction. The guideline panel says every fiber trial behind its recommendation is 30 to 40 years old, small and mostly in women, and that even the psyllium data, the best there are, are of low quality.

What the trials found

The 2022 meta-analysis pooled 16 randomized trials of fiber supplements in 1,251 adults with chronic constipation. Psyllium added 3.08 bowel movements a week over control, the largest gain of any fiber, with an interval from 0.61 to 5.54. The trials disagreed sharply on the size, so treat 3 as a rough figure. Psyllium was the only fiber that eased straining, a standardized difference of minus 0.65, and it softened stools as well. Across all fiber types, response came only at doses above 10 g a day, whatever the length of treatment.

The AGA-ACG pooling used 3 trials of 22, 201 and 35 people. Two had unclear randomization, one lost many participants, and one used a mix of celandine, aloe and psyllium rather than psyllium alone. That is why the certainty is low even though the result points one way.

Against another fiber, psyllium held its own. In a double-blind trial of 72 constipated adults, 5 g twice a day for 4 weeks gave a 75% response rate, the same as a plum-derived fiber mix. That trial had no placebo arm, so the 75% includes people who would have improved anyway. For the wider group of functional bowel disorders, a 2026 review of 10 short trials found psyllium improved stool consistency, and the trials were too varied to pool.

One trial looked at a different group and a different outcome. In 50 people in Spain with functional dyspepsia, constipation and poorly coordinated pelvic floor muscles during defecation, 3.5 g of Plantago ovata a day for 4 weeks did not reduce fullness after meals, while biofeedback that corrected the defecation problem did. That dose was below the 10 g threshold, and the trial did not report bowel movement frequency.

Who should be careful

In the constipation trials the side effects were minor. Adverse events were reported unevenly and not pooled. In one small trial, 2 people on psyllium (18%) had abdominal pain against none on control. Across all fiber types, flatulence was higher than on control. Among 72 adults in the head-to-head trial, wind improved in 25% on psyllium against 53% on the plum fiber mix. For people who get bloating, pain or wind on psyllium, the British Dietetic Association suggests kiwifruit instead.

Not for everyone. Psyllium needs fluid. US rules require every psyllium product to warn that, taken without enough fluid, it can swell and block the throat or esophagus and cause choking, and to tell you to take it with at least 8 ounces of liquid. Two case reports describe blockages. A 76-year-old man with Parkinson's disease needed endoscopy for a 2 by 0.98 in (2.5 cm) psyllium mass near the junction of his esophagus and stomach. A 26-year-old man on an extreme slimming diet developed bowel obstruction after psyllium diet food, and the authors warn about taking psyllium without enough fluid. Both are single cases.

Allergy has been documented, mostly in people who handle the powder. A 60-year-old nurse who had dispensed psyllium laxatives developed anaphylaxis the first time she ate a psyllium cereal, and a 24-year-old baker developed confirmed occupational rhinitis from psyllium in gluten-free baking. Laxative users, healthcare workers and pharmaceutical workers are named as groups at risk of sensitization. These are single cases and cannot say how often it happens.

On medicines, in 30 older inpatients taking digoxin, 4 weeks of an ispaghula bulk laxative did not change blood digoxin levels. In 18 people with Parkinson's disease, Plantago ovata husk did not lower levodopa exposure. Those are two small studies and two drugs. We did not review other medicines, so anyone on regular medication should ask a pharmacist how to time psyllium around it. In pregnancy, a Cochrane review found one trial of 140 women where stimulant laxatives improved constipation more than bulk-forming laxatives such as psyllium, a risk ratio of 1.59, and also caused more abdominal discomfort, a risk ratio of 2.33. Psyllium was the comparator there, not tested against placebo. We found no randomized trial of psyllium in constipated children.

What expert bodies say

The AGA and ACG make a conditional recommendation for fiber supplements in chronic idiopathic constipation, with psyllium the best-supported of them. The British Dietetic Association, in 2025, advises fiber supplement doses above 10 g a day and at least 4 weeks before judging the result. It built that dose threshold from all fiber types together, not from psyllium alone.

How we searched

What would change this answer

• A modern placebo-controlled trial, large enough to measure the effect properly, with complete bowel movements and responder rates as outcomes. That is what would lift the certainty above low.
• Trials that include more men and older adults. The existing ones are mostly in women.
• Any randomized trial of psyllium in constipated children. We found none.

For the supplement itself, including its effect on cholesterol, see the psyllium husk page.

Sources

1. ev-psy-01 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized controlled trials · n = 3 trials
   Subgroup analyses showed significantly greater responses to treatment in the 3 trials of psyllium supplementation, with no significant heterogeneity [RR: 1.82 (95% CI: 1.51, 2.20; P < 0.00001); I2 = 0% (P = 0.98)]
   
   Who: Adults with chronic constipation, 3 RCTs of psyllium within 16 RCTs of fiber supplements
   Effect: response RR 1.82 (95% CI 1.51 to 2.20), I2 0%; all fiber RR 1.48 (1.17 to 1.88)
   Certainty: Three trials only. Response definitions varied between trials.
   Am J Clin Nutr, 2022 · checked 2026-10-06 · we read the fulltext
2. ev-psy-02 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized controlled trials · n = —
   Psyllium significantly increased stool frequency by +3.08 bowel movements/week [95% CI: 0.61, 5.54 bowel movements/week; P = 0.01; I2 = 90% (P < 0.0001)]
   
   Who: Adults with chronic constipation, psyllium subgroup of the stool frequency analysis
   Effect: stool frequency MD +3.08 bowel movements/week (95% CI 0.61 to 5.54), I2 90%; all fiber +1.19 (0.59 to 1.78)
   Certainty: Very high heterogeneity (I2 90%), so the size of the gain is uncertain even though its direction is consistent.
   Am J Clin Nutr, 2022 · checked 2026-10-06 · we read the fulltext
3. ev-psy-03 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized controlled trials · n = —
   Subgroup analyses showed that only psyllium significantly improved straining severity [SMD: −0.65 (95% CI: −0.91, −0.39; P < 0.00001); I2 = 0% (P = 0.67)], while polydextrose and inulin-type fructans did not (Figure 5).
   
   Who: Adults with chronic constipation, psyllium subgroups for straining and stool consistency
   Effect: straining SMD -0.65 (95% CI -0.91 to -0.39), I2 0%; stool consistency SMD 0.52 (0.25 to 0.78), I2 0%
   Certainty: Standardized effects from few trials; moderate in size.
   Am J Clin Nutr, 2022 · checked 2026-10-06 · we read the fulltext
4. ev-psy-04 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized controlled trials, adverse events narrative · n = —
   One study administering psyllium reported that 2 participants (18%) in the intervention group had abdominal pain, compared to none in the control group (28).
   
   Who: Psyllium trials within a meta-analysis of fiber in chronic constipation
   Effect: abdominal pain 18% vs 0% in one small trial; no serious adverse events in two psyllium trials
   Certainty: Adverse events were reported inconsistently and not pooled.
   Am J Clin Nutr, 2022 · checked 2026-10-06 · we read the fulltext
5. ev-psy-05 · Meta-analysis or systematic review · GRADE guideline with meta-analysis of randomized controlled trials · n = 258
   Based on the meta-analysis of data from 3 studies (29–31), the use of psyllium may lead to an increase in SBMs per week (MD 2.32, CI 0.86–3.79). Combined data from 2 studies showed that the use of psyllium may increase global relief symptoms (RR 1.86, CI 1.49–2.30)
   
   Who: Adults with chronic idiopathic constipation, 3 RCTs of psyllium vs placebo (22, 201 and 35 participants)
   Effect: SBM per week MD 2.32 (95% CI 0.86 to 3.79); global relief RR 1.86 (1.49 to 2.30), 391 more per 1,000
   Certainty: Low certainty: unclear randomization in 2 trials, high attrition in one, one trial used a celandine-aloe-psyllium mix. Conditional recommendation for fiber.
   Am J Gastroenterol, 2023 · checked 2026-10-06 · we read the fulltext
6. ev-psy-06 · Position of an expert body · evidence appraisal within a GRADE clinical practice guideline · n = —
   All studies are 30–40 years old, and the number of participants in the studies has been small and most are primarily conducted in women. Most of the included studies on fiber supplementation did not report on relevant patient important outcomes. The best data exist for psyllium, but even those are of low quality.
   
   Who: Guideline panel appraisal of fiber trials in chronic idiopathic constipation
   Effect: evidence gap stated; certainty low
   Certainty: A statement about the evidence base, not an effect.
   Am J Gastroenterol, 2023 · checked 2026-10-06 · we read the fulltext
7. ev-psy-07 · Position of an expert body · evidence-based good-practice statement in a GRADE dietary guideline · n = —
   Fibre supplement doses above 10 g/d are optimal for increasing the number of people with constipation who have a clinical benefit, improving stool output and reducing the severity of straining (evidence‐based recommendation). Consuming fibre supplements for a minimum duration of 4 weeks is optimal for increasing stool frequency and improving global constipation symptoms of constipation (evidence‐based recommendation).
   
   Who: Adults with chronic constipation, BDA 2025 guideline good-practice statements
   Effect: dose above 10 g/day; minimum 4 weeks
   Certainty: Dose threshold derived from subgroup analysis of all fiber types, not psyllium alone.
   J Hum Nutr Diet, 2025 · checked 2026-10-06 · we read the fulltext
8. ev-psy-08 · Position of an expert body · good-practice statements in a GRADE dietary guideline · n = —
   Kiwifruit may be a preferred option over psyllium in people with constipation who experience side effects such as bloating, abdominal pain and flatulence (evidence‐based recommendation).
   
   Who: Adults with chronic constipation who do not tolerate psyllium
   Effect: kiwifruit preferred where psyllium causes side effects; gradual weekly increments; additional fluid
   Certainty: The kiwifruit statement is evidence-based; the gradual increase and fluid statements are expert opinion.
   J Hum Nutr Diet, 2025 · checked 2026-10-06 · we read the fulltext
9. ev-psy-09 · Randomized controlled trial(s) · randomized double-blind controlled trial, active comparator · n = 72
   There were 30 (75%) responders with mixed fibre and 24 (75%) with psyllium (P = 0.9).
   
   Who: Adults with Rome III constipation, mixed fiber 40, psyllium 32
   Effect: responders 75% vs 75% (P = 0.9); flatulence improved in 25% on psyllium vs 53% on mixed fiber (P = 0.01)
   Certainty: No placebo arm, so the 75% includes placebo response.
   Aliment Pharmacol Ther, 2016 · checked 2026-10-06 · we read the abstract
10. ev-psy-10 · Meta-analysis or systematic review · Cochrane systematic review of randomized and quasi-randomized trials · n = 140
    Compared to bulk-forming laxatives, pregnant women who received stimulant laxatives had significantly more improvement in constipation (risk ratio (RR) 1.59, 95% confidence interval (CI) 1.21 to 2.09; 140 women, one study, moderate quality of evidence), but also significantly more abdominal discomfort (RR 2.33, 95% CI 1.15 to 4.73; 140 women, one study, low quality of evidence)
    
    Who: Pregnant women with constipation, 4 studies included, 2 with 180 women contributing data
    Effect: improvement RR 1.59 (95% CI 1.21 to 2.09) for stimulant vs bulk-forming; abdominal discomfort RR 2.33 (1.15 to 4.73)
    Certainty: One trial of unclear randomization; moderate to low quality evidence. Bulk-forming laxatives were the comparator, not tested against placebo.
    Cochrane Database Syst Rev, 2015 · checked 2026-10-06 · we read the abstract
11. ev-psy-11 · Randomized controlled trial(s) · randomized comparative trial, 4 weeks · n = 30
    Ispaghula had no influence at any time. It is concluded that neither wheat bran nor the ispaghula formulation has any clinically relevant influence on therapeutic digoxin levels in geriatric patients.
    
    Who: 30 geriatric in-patients on digoxin, 14 on ispaghula, 16 on wheat bran
    Effect: no influence of ispaghula on steady-state digoxin at 2 or 4 weeks
    Certainty: Small and old (1987); one drug only. Says nothing about other narrow-margin drugs.
    Drug Nutr Interact, 1987 · checked 2026-10-06 · we read the abstract
12. ev-psy-12 · Laboratory or animal data · case series · n = 1
    We report a case of a 60-year-old woman with no prior history of psyllium ingestion who developed anaphylactic symptoms after eating a psyllium-containing cereal. Her only previous exposure was dispensing a psyllium-containing laxative as a nurse.
    
    Who: One 60-year-old woman, previous exposure only by dispensing psyllium laxative
    Effect: IgE-mediated anaphylaxis confirmed by skin test and basophil histamine release
    Certainty: Single case. Shows sensitization by inhalation in people who handle the powder.
    JAMA, 1990 · checked 2026-10-06 · we read the abstract
13. ev-psy-13 · Laboratory or animal data · case series · n = 1
    Since patients undergoing extreme slimming regimens may cause intestinal obstruction if psyllium is taken without adequate fluid intake caution should be taken when eating psyllium.
    
    Who: One 26-year-old man on an extreme slimming regimen
    Effect: intestinal obstruction
    Certainty: Single case report.
    Acute Med Surg, 2023 · checked 2026-10-06 · we read the abstract
14. ev-psy-14 · Randomized controlled trial(s) · randomized parallel trial at 2 referral centers · n = 50
    Fiber supplementation did not reduce postprandial fullness or anal evacuations (P ≤ .023 between groups for both parameters in the intent to treat analysis).
    
    Who: 50 patients meeting Rome IV criteria for functional dyspepsia with functional constipation and dyssynergic defecation, Spain
    Effect: fiber did not reduce postprandial fullness or anal gas evacuations; biofeedback cut fullness by 22%
    Certainty: Low fiber dose (3.5 g, below the 10 g threshold) and an outcome other than stool frequency.
    Clin Gastroenterol Hepatol, 2020 · checked 2026-10-06 · we read the abstract
15. psyl-r1-06 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs · n = 1251
    Overall, 311 of 473 (66%) participants responded to fiber treatment and 134 of 329 (41%) responded to control treatment [RR: 1.48 (95% CI: 1.17, 1.88; P = 0.001); I2 = 57% (P = 0.007)], with psyllium and pectin having significant effects. A higher response to treatment was apparent in fiber groups compared to control groups irrespective of the treatment duration, but only with higher fiber doses (>10 g/d).
    
    Who: 16 RCTs, 1251 adults with chronic constipation
    Effect: response RR 1.48 (95% CI 1.17 to 1.88); stool frequency SMD 0.72; flatulence higher (SMD 0.80)
    Certainty: Pooled across fiber types, high heterogeneity (I2 57 to 86%).
    Am J Clin Nutr, 2022 · checked 2026-10-03 · we read the abstract
16. psyl-r1-11 · Randomized controlled trial(s) · randomized crossover trial · n = 18
    18 volunteers participated in the study and received alternatively two treatments (Plantago ovata husk or placebo) with their usual levodopa/carbidopa oral dose. ... AUC was very similar in the three groups: initial situation.- 62.87 μg.min/ml, fiber treatment.- 64.47 μg.min/ml and placebo treatment.- 65.10 μg.min/ml.
    
    Who: 18 Parkinson patients on their usual levodopa/carbidopa dose, husk or placebo
    Effect: levodopa AUC 64.47 vs 65.10 ug.min/ml; Cmax 547.8 vs 612.0 ng/ml
    Certainty: One drug, small trial. Labels still advise asking a pharmacist about other medicines.
    BMC Complement Altern Med, 2014 · checked 2026-10-03 · we read the abstract
17. psyl-r1-13 · Position of an expert body · US regulation · n = —
    Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking.
    
    Who: US over-the-counter products containing hydrophilic gums and mucilloids such as psyllium
    Effect: mandatory choking warning; at least 8 ounces (a full glass) of water or other fluid per dose
    Certainty: Regulatory warning. Quote checked by eye in two independent requests (eCFR API and a DailyMed psyllium label), not by machine.
    21 CFR 201.319, water-soluble gums, hydrophilic gums, and hydrophilic mucilloids, required warnings · checked 2026-10-03 · we read the section
18. psyl-r1-14 · Laboratory or animal data · case series · n = 1
    A 76-year-old male with Parkinson's disease visited the emergency department with swallowing difficulty approximately 10 h after ingesting psyllium seed husk powder. ... However, a computed tomography scan revealed an approximately 2.0 cm × 2.5 cm mass located near the gastro-esophageal junction.
    
    Who: one 76-year-old man with Parkinson's disease
    Effect: esophageal bezoar about 2.0 by 0.98 in (2.5 cm), removed endoscopically
    Certainty: Single case report. Fluid volume taken not given in the abstract.
    World J Clin Cases, 2022 · checked 2026-10-03 · we read the abstract
19. psyl-r1-15 · Laboratory or animal data · case series · n = 1
    Consumers using psyllium-containing laxatives, healthcare workers handling these, and pharmaceutical workers in laxative-manufacturing plants are known to be at risk of sensitization and subsequent rhinitis, asthma, contact urticaria, and even anaphylaxis.
    
    Who: one 24-year-old female baker
    Effect: skin prick wheal 10 mm to psyllium; nasal provocation confirmed occupational allergic rhinitis
    Certainty: Single case. The abstract names laxative users, healthcare and pharmaceutical workers as known at-risk groups.
    Am J Ind Med, 2021 · checked 2026-10-03 · we read the abstract
20. psyl-r1-19 · Meta-analysis or systematic review · systematic review of RCTs · n = 10 trials
    Ten studies reporting eight parallel and two crossover RCTs evaluating differing fibre supplements and doses for people with various types of FBD were included. ... psyllium improved stool consistency ... though high heterogeneity precluded meta-analysis.
    
    Who: 10 RCTs in adults with functional bowel disorders, 11 to 250 participants, 1 to 8 weeks
    Effect: psyllium improved stool consistency; no pooled estimate
    Certainty: Narrative synthesis, short small trials. Long-term effects unknown.
    Clin Nutr ESPEN, 2026 · checked 2026-10-03 · we read the abstract